@Article{,
AUTHOR = {Daniel Zwahlen, Paula N. Fishman, John Honey,
Michael Milosevic, Ian Tannock},
TITLE = {Malignant pheochromocytoma of the urinary bladder},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {14},
YEAR = {2007},
NUMBER = {1},
PAGES = {3455--3457},
URL = {http://www.techscience.com/CJU/v14n1/62430},
ISSN = {1488-5581},
ABSTRACT = {This report describes an illustrative case of malignant
pheochromocytoma of the urinary bladder in a 28-year old
man. A combined-modality treatment plan with partial
cystectomy and post-operative radiotherapy and concurrent
chemotherapy with single agent cisplatin weekly was
performed. Three weeks after completing concurrent
chemoradiation the first of four planned cycles of cisplatin 25
mg/m<sup>2</sup>
 andetoposide 100 mg/m<sup>2</sup>
 was administered daily over
3 days. Although there are no controlled series offering proof
of benefit, postoperative concurrent chemoradiation followed
by chemotherapy alone are reasonable options for patients
with residual disease or at high risk for locoregional relapse.},
DOI = {}
}